Healthcare & Life Sciences
Oxford BioTherapeutics
United Kingdomwww.oxfordbiotherapeutics.com
Oxford BioTherapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series B, 3 tracked investors.
activeseries-b
series-b
Stage
2015
Founded
3
Investors
About Oxford BioTherapeutics
Oxford BioTherapeutics is a company founded in 2015 headquartered in the United Kingdom. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Oxford BioTherapeutics is a clinical-stage oncology company developing first-in-class antibody-based therapies, including Antibody-Drug Conjugates (ADCs) and T-cell engagers (TCEs), to improve patient outcomes in cancer treatment.
Explore Oxford BioTherapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.